Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
29.32 USD | +1.35% | -0.27% | -9.23% |
Apr. 11 | Harmony Biosciences, Bioprojet Enter Licensing Deal for Sleep Disorder Therapy | MT |
Apr. 03 | Harmony Biosciences Begins Phase 3 Trial of Pitolisant to Treat Prader-Willi Syndrome Symptoms | MT |
Financials (USD)
Sales 2024 * | 711M | Sales 2025 * | 840M | Capitalization | 1.67B |
---|---|---|---|---|---|
Net income 2024 * | 180M | Net income 2025 * | 247M | EV / Sales 2024 * | 1.83 x |
Net cash position 2024 * | 367M | Net cash position 2025 * | 646M | EV / Sales 2025 * | 1.21 x |
P/E ratio 2024 * |
9.94
x | P/E ratio 2025 * |
7.21
x | Employees | 246 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 58.66% |
Latest transcript on Harmony Biosciences Holdings, Inc.
1 day | +1.35% | ||
1 week | -0.27% | ||
Current month | -12.69% | ||
1 month | -8.43% | ||
3 months | -5.66% | ||
6 months | +49.82% | ||
Current year | -9.23% |
Managers | Title | Age | Since |
---|---|---|---|
Jeffrey Dayno
CEO | Chief Executive Officer | 66 | 17-10-31 |
Director of Finance/CFO | 53 | 21-03-28 | |
David Bradshaw
CTO | Chief Tech/Sci/R&D Officer | 62 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeffrey Aronin
FOU | Founder | 56 | 17-07-24 |
R. Graf
BRD | Director/Board Member | 59 | 20-11-10 |
Andreas Wicki
BRD | Director/Board Member | 64 | 17-08-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.52% | 16 M€ | -8.49% | ||
0.35% | 29 M€ | -4.33% | ||
0.31% | 27 M€ | -5.03% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 29.32 | +1.35% | 376,165 |
24-04-25 | 28.93 | -1.03% | 313,048 |
24-04-24 | 29.23 | +1.32% | 374,235 |
24-04-23 | 28.85 | -1.70% | 425,156 |
24-04-22 | 29.35 | -0.17% | 298,843 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.23% | 1.67B | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- HRMY Stock